Semin Respir Crit Care Med 2021; 42(02): 218-232
DOI: 10.1055/s-0041-1723953
Review Article

Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents

Hannah Stevens
1  Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
2  Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
3  Department of Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia
,
James McFadyen
1  Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
2  Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
3  Department of Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia
,
Noel Chan
4  Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations

Abstract

Important advances in the understanding and management of venous thromboembolism (VTE) have enhanced our ability to diagnose, prevent, and treat VTE. In this narrative review, we discuss how recent advances in the understanding and management of VTE are changing practice, highlight ongoing unmet needs in VTE management, and outline how novel therapeutic targets with little or no influence on hemostasis may help address these unmet needs.



Publication History

Publication Date:
18 February 2021 (online)

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA